Beam Therapeutics Inc.BEAMNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank25
3Y CAGR-16.0%
5Y CAGR-32.3%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
-16.0%/yr
vs -6.6%/yr prior
5Y CAGR
-32.3%/yr
Recent acceleration
Acceleration
-9.3pp
Decelerating
Percentile
P25
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineElevated
PeriodValueYoY Change
20252.21-20.4%
20242.78+30.0%
20232.14-42.7%
20223.73-39.7%
20216.19-60.2%
202015.54+62.9%
20199.54+94.0%
20184.92+108.5%
2017-58.06-